68

InventisBio Co LtdSHG 688382 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

1.252

Small

Exchange

XSHG - Shanghai Stock Exchange

688382.SS Stock Analysis

68

Uncovered

InventisBio Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-17/100

Low score

Market cap $B

1.252

Dividend yield

Shares outstanding

575 B

InventisBio Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai and currently employs 155 full-time employees. The company went IPO on 2022-07-25. InventisBio Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The firm's main product is still in clinical development. The firm's core products mainly focus on major disease areas such as oncology and metabolic diseases. The firm's products include D-0120, D-0502, D-1553, BPI-D0316 and others.

View Section: Eyestock Rating